Business news

Affymax Completes Enrollment in Phase 3 Program for Hematide in ... - (press release) PDF Print

Consistent with our previous guidance, we expect to submit a New Drug Application for Hematide in chronic renal failure in 2010 if all goes as planned. ...

read more

Fresenius Medical Care honored for patient care - PDF Print

Fresenius Medical Care North America, operator of dialysis facilities, has named Fresenius Medical Care, 1536 W. Center Road, Hampton Township, ...

read more

Il portafoglio di Borsainside sale controtendenza - Borsa PDF Print

Tra i titoli del nostro portafoglio si sono messi in luce East Japan Railway (+6,6% settimanale) e Fresenius Medical Care (+5,7%). ...

read more

Theratechnologies completes Phase III HIV-associated lipodystrophy ... - Pharmaceutical Business Review PDF Print

By Staff Writer The confirmatory Phase III trial is a 400-patient, multi-center, double-blind, randomized, placebo-controlled study conducted in 48 centers ...

read more

Affymax Inc - Premium Company Profile - New Research Report on ... - (Pressemitteilung) PDF Print

The company´s most advanced product candidate Hematide, a synthetic peptide-based erythropoiesis-stimulating agent (ESA). Affymax´s product focus is in the ...

read more

<< Start < Prev 131 132 133 134 135 136 137 138 Next > End >>

Page 138 of 138
Share |
Copyright © 2018 Global Dialysis. All Rights Reserved.